← Back to Clinical Trials
Recruiting NCT06539312

NCT06539312 Project ASTHMA - Aligning With Schools To Help Manage Asthma and Improve Outcomes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06539312
Status Recruiting
Phase
Sponsor State University of New York at Buffalo
Condition Asthma in Children
Study Type INTERVENTIONAL
Enrollment 400 participants
Start Date 2024-09-27
Primary Completion 2028-04-30

Eligibility & Interventions

Sex All sexes
Min Age 4 Years
Max Age 13 Years
Study Type INTERVENTIONAL
Interventions
APP assessment and management of asthma

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 400 participants in total. It began in 2024-09-27 with a primary completion date of 2028-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Children with asthma from communities that experience health inequities frequently do not receive guideline-based asthma care, and as a result, account for a disproportionate percentage of asthma exacerbations, emergency department visits, and hospitalizations. Project ASTHMA (Aligning with Schools To Help Manage Asthma) tests the effectiveness of school-based health centers as a delivery model to improve health outcomes by providing children with guideline-based asthma assessments and preventive medication management, directly observed therapy of their preventive medication to support adherence, and self-management support. If successful, this multicomponent intervention will represent a cost effective and sustainable model to reduce asthma morbidity in historically marginalized communities, and has the potential to impact communities throughout the United States where over 2,500 school-based health centers operate.

Eligibility Criteria

Inclusion Criteria: * uncontrolled asthma Exclusion Criteria: * other chronic lung disease such as cystic fibrosis

Contact & Investigator

Central Contact

Lucy CY Holmes, MD, MPH

✉ LHolmes@upa.chob.edu

📞 716-323-0034

Frequently Asked Questions

Who can join the NCT06539312 clinical trial?

This trial is open to participants of all sexes, aged 4 Years or older, up to 13 Years, studying Asthma in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06539312 currently recruiting?

Yes, NCT06539312 is actively recruiting participants. Contact the research team at LHolmes@upa.chob.edu for enrollment information.

Where is the NCT06539312 trial being conducted?

This trial is being conducted at Buffalo, United States.

Who is sponsoring the NCT06539312 clinical trial?

NCT06539312 is sponsored by State University of New York at Buffalo. The trial plans to enroll 400 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology